These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 17019652)
1. Postnatal lethality and cardiac anomalies in the Ts65Dn Down syndrome mouse model. Moore CS Mamm Genome; 2006 Oct; 17(10):1005-12. PubMed ID: 17019652 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the cardiac phenotype in neonatal Ts65Dn mice. Williams AD; Mjaatvedt CH; Moore CS Dev Dyn; 2008 Feb; 237(2):426-35. PubMed ID: 18161058 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular development and survival during gestation in the Ts65Dn mouse model for Down syndrome. Lorandeau CG; Hakkinen LA; Moore CS Anat Rec (Hoboken); 2011 Jan; 294(1):93-101. PubMed ID: 21157920 [TBL] [Abstract][Full Text] [Related]
4. The pattern of congenital heart defects arising from reduced Tbx5 expression is altered in a Down syndrome mouse model. Polk RC; Gergics P; Steimle JD; Li H; Moskowitz IP; Camper SA; Reeves RH BMC Dev Biol; 2015 Jul; 15():30. PubMed ID: 26208718 [TBL] [Abstract][Full Text] [Related]
5. Perinatal loss of Ts65Dn Down syndrome mice. Roper RJ; St John HK; Philip J; Lawler A; Reeves RH Genetics; 2006 Jan; 172(1):437-43. PubMed ID: 16172497 [TBL] [Abstract][Full Text] [Related]
6. Penetrance of Congenital Heart Disease in a Mouse Model of Down Syndrome Depends on a Trisomic Potentiator of a Disomic Modifier. Li H; Edie S; Klinedinst D; Jeong JS; Blackshaw S; Maslen CL; Reeves RH Genetics; 2016 Jun; 203(2):763-70. PubMed ID: 27029737 [TBL] [Abstract][Full Text] [Related]
8. Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes. Olson LE; Roper RJ; Baxter LL; Carlson EJ; Epstein CJ; Reeves RH Dev Dyn; 2004 Jul; 230(3):581-9. PubMed ID: 15188443 [TBL] [Abstract][Full Text] [Related]
9. Ts65Dn -- localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome. Akeson EC; Lambert JP; Narayanswami S; Gardiner K; Bechtel LJ; Davisson MT Cytogenet Cell Genet; 2001; 93(3-4):270-6. PubMed ID: 11528125 [TBL] [Abstract][Full Text] [Related]
10. Sexually dimorphic DYRK1A overexpression on postnatal day 15 in the Ts65Dn mouse model of Down syndrome: Effects of pharmacological targeting on behavioral phenotypes. Hawley LE; Prochaska F; Stringer M; Goodlett CR; Roper RJ Pharmacol Biochem Behav; 2022 Jun; 217():173404. PubMed ID: 35576991 [TBL] [Abstract][Full Text] [Related]
11. Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome. Richtsmeier JT; Zumwalt A; Carlson EJ; Epstein CJ; Reeves RH Am J Med Genet; 2002 Feb; 107(4):317-24. PubMed ID: 11840489 [TBL] [Abstract][Full Text] [Related]
12. Developmental instability of the cerebellum and its relevance to Down syndrome. Shapiro BL J Neural Transm Suppl; 2001; (61):11-34. PubMed ID: 11771737 [TBL] [Abstract][Full Text] [Related]
13. Mouse models of Down syndrome: gene content and consequences. Gupta M; Dhanasekaran AR; Gardiner KJ Mamm Genome; 2016 Dec; 27(11-12):538-555. PubMed ID: 27538963 [TBL] [Abstract][Full Text] [Related]
14. Genetic modifiers predisposing to congenital heart disease in the sensitized Down syndrome population. Li H; Cherry S; Klinedinst D; DeLeon V; Redig J; Reshey B; Chin MT; Sherman SL; Maslen CL; Reeves RH Circ Cardiovasc Genet; 2012 Jun; 5(3):301-8. PubMed ID: 22523272 [TBL] [Abstract][Full Text] [Related]
15. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Baxter LL; Moran TH; Richtsmeier JT; Troncoso J; Reeves RH Hum Mol Genet; 2000 Jan; 9(2):195-202. PubMed ID: 10607830 [TBL] [Abstract][Full Text] [Related]
16. Embryonic and not maternal trisomy causes developmental attenuation in the Ts65Dn mouse model for Down syndrome. Blazek JD; Billingsley CN; Newbauer A; Roper RJ Dev Dyn; 2010 Jun; 239(6):1645-53. PubMed ID: 20503361 [TBL] [Abstract][Full Text] [Related]
17. Novel insights from fetal and placental phenotyping in 3 mouse models of Down syndrome. Adams AD; Hoffmann V; Koehly L; Guedj F; Bianchi DW Am J Obstet Gynecol; 2021 Sep; 225(3):296.e1-296.e13. PubMed ID: 33766516 [TBL] [Abstract][Full Text] [Related]
18. Abnormal mineralization of the Ts65Dn Down syndrome mouse appendicular skeleton begins during embryonic development in a Dyrk1a-independent manner. Blazek JD; Malik AM; Tischbein M; Arbones ML; Moore CS; Roper RJ Mech Dev; 2015 May; 136():133-42. PubMed ID: 25556111 [TBL] [Abstract][Full Text] [Related]
19. Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome. Kahlem P; Sultan M; Herwig R; Steinfath M; Balzereit D; Eppens B; Saran NG; Pletcher MT; South ST; Stetten G; Lehrach H; Reeves RH; Yaspo ML Genome Res; 2004 Jul; 14(7):1258-67. PubMed ID: 15231742 [TBL] [Abstract][Full Text] [Related]
20. Increased male reproductive success in Ts65Dn "Down syndrome" mice. Moore CS; Hawkins C; Franca A; Lawler A; Devenney B; Das I; Reeves RH Mamm Genome; 2010 Dec; 21(11-12):543-9. PubMed ID: 21110029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]